Literature DB >> 3515937

Serratia marcescens osteomyelitis of the clavicle and sternoclavicular arthritis complicating infected indwelling subclavian vein catheter.

C Watanakunakorn.   

Abstract

Serratia marcescens bacteremia, osteomyelitis of the right clavicle, and septic arthritis of the right sternoclavicular joint developed in a 69-year-old woman after a right subclavian vein catheter was in place for five days. The infections were cured with the combination of gentamicin and ceftizoxime. There have been three previously reported cases of osteomyelitis of the clavicle following indwelling subclavian vein catheterization; two were caused by Staphylococcus aureus and one by Pseudomonas aeruginosa.

Entities:  

Mesh:

Year:  1986        PMID: 3515937     DOI: 10.1016/0002-9343(86)90840-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Osteomyelitis of the clavicle: clinical, radiologic, and bacteriologic findings in ten patients.

Authors:  E O Gerscovich; A Greenspan
Journal:  Skeletal Radiol       Date:  1994-04       Impact factor: 2.199

2.  Sternoclavicular septic arthritis: a rare but serious complication of subclavian venous catheterization.

Authors:  F Aglas; J Gretler; F Rainer; G J Krejs
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

3.  Post-traumatic osteomyelitis of the clavicle: A case report and review of literature.

Authors:  Chenicheri Balakrishnan; Christopher Vashi; Ollie Jackson; Jason Hess
Journal:  Can J Plast Surg       Date:  2008

4.  Severe Osteomyelitis and Septic Arthritis due to Serratia marcescens in an Immunocompetent Patient.

Authors:  Hiba Hadid; Muhammad Usman; Sudeep Thapa
Journal:  Case Rep Infect Dis       Date:  2015-06-15

Review 5.  Similarities and Differences between Clavicular Bacterial Osteomyelitis and Nonbacterial Osteitis: Comparisons of 327 Reported Cases.

Authors:  Nan Jiang; Ping Zhang; Wei-Ran Hu; Zi-Long Yao; Bin Yu
Journal:  J Immunol Res       Date:  2021-01-26       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.